You have been staying up late two nights in a row working from home finishing office work.
There’s a big presentation coming up tomorrow morning and you want to get good sleep.
After half an hour of tossing and turning in bed, you decide to take a sleeping pill to aid you to restful slumber.
How convenient life is with these little medical aids. Or is it?
Recent study conducted by researchers at the Scripps Clinic showed that people using sleeping pills fairly regularly were at a 4.6 times higher risk of death than those who did not use the sleeping medications.
The research also discovered during the course of the study that regular usage of sleeping pills significantly raised a person’s chances of developing cancers. (1)
This finding has served as a warning to the medical fraternity and the pharmaceutical industry for prescribing and selling these drugs instead of finding a better alternative.
It is to be noted that the sales in the sleeping pills segment of the pharmaceutical industry increased by 23 percent in the past half-decade, generating an yearly sale of 2 billion dollars!
According to lead author of the study, Daniel F. Kripke, MD, of the Viterbi Family Sleep Center at Scripps Health in San Diego, “What our study shows is that sleeping pills are hazardous to your health and might cause death by contributing to the occurrence of cancer, heart disease and other ailments.” (2)
What was most surprising in the study was the discovery of drugs that were thought to be safer than older drugs due to their short action time turned out to be the most harmful.
They were also linked to the greatest increase in the risk of mortality and cancer. The drugs are zolpidem sold under the brand name of Ambien and, temazepam sold as Restoril.
The study observed that the risk of death was high, even for adult patients who only had anything between 1-18 sleeping pills a year. These patients were 3.6 times more likely to have fatal outcomes than those who did not take the pills.
The other finding of the study about the probability of developing cancer was equally shocking.